A
Accustem Sciences Ltd
OTC:ACUT
Accustem Sciences Ltd
OTC:ACUT
Price:
0.4703
USD
-8.45%
Market Closed
Market Cap:
$7.6m
Accustem Sciences Ltd
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Accustem Sciences Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Accustem Sciences Ltd
OTC:ACUT
|
Research & Development
-$138.3k
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$8.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$5.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$7.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$5.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-12%
|
|
No Stocks Found
Accustem Sciences Ltd
Glance View
The company is headquartered in New York City, New York. The company went IPO on 2021-07-09.
ACUT
Intrinsic Value
Not Available
A
See Also
What is Accustem Sciences Ltd's Research & Development?
Research & Development
-138.3k
USD
-138.3k
USD
Based on the financial report for Dec 31, 2024, Accustem Sciences Ltd's Research & Development amounts to -138.3k USD.
What is Accustem Sciences Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-24%
-24%
Over the last year, the Research & Development growth was 1%. The average annual Research & Development growth rates for Accustem Sciences Ltd have been -24% over the past three years .
